Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Emerging uses of PARP inhibitors

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA
Emerging uses of PARP inhibitors ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )
8 May 2019

Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer

Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA
Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )
8 May 2019

Treating ovarian cancers with PARP inhibitors

Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA
Treating ovarian cancers with PARP inhibitors ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )
8 May 2019

Managing the side effects of CAR T-cell therapy

Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA
Managing the side effects of CAR T-cell therapy ( Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA )
8 May 2019

Anti-cancer compound for brain cancer found in daffodils

Dr Lorenzo Caggiano - University of Bath, Bath, UK
Anti-cancer compound for brain cancer found in daffodils ( Dr Lorenzo Caggiano - University of Bath, Bath, UK )
2 May 2019

The Brain Tumour Charity

Ms Erica Moyes - The Brain Tumour Charity, Farnborough, UK
The Brain Tumour Charity ( Ms Erica Moyes - The Brain Tumour Charity, Farnborough, UK )
2 May 2019

How the WIN consortium achieves its goals

Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019

The translational element of the WIN consortium

Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019

Making oncology global with the WIN consortium

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019

An overview of the WIN consortium

Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019

The WIN symposium 2019

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019

Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC

Prof Tony Mok - Chinese University of Hong Kong, Hong Kong
Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC ( Prof Tony Mok - Chinese University of Hong Kong, Hong Kong )
18 Apr 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation